Integrating Models to Quantify Environment-Mediated Drug Resistance.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28754669.
- Also identified by DOI 10.1158/0008-5472.CAN-17-0835 and PMC identifier 8455089.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drug resistance is the single most important driver of cancer treatment failure for modern targeted therapies, and the dialog between tumor and stroma has been shown to modulate the response to molecularly targeted therapies through proliferative and survival signaling. In this work, we investigate interactions between a growing tumor and its surrounding stroma and their role in facilitating the emergence of drug resistance. We used mathematical modeling as a theoretical framework to bridge between experimental models and scales, with the aim of separating intrinsic and extrinsic components of resistance in <i>BRAF</i>-mutated melanoma; the model describes tumor-stroma dynamics both with and without treatment. Integration of experimental data into our model revealed significant variation in either the intensity of stromal promotion or intrinsic tissue carrying capacity across animal replicates. <i>Cancer Res; 77(19); 5409-18. ©2017 AACR</i>.
Medical subject headings
- Drug Resistance, Neoplasm
- Focal Adhesion Kinase 1
- Melanoma
- Models, Theoretical
- Molecular Targeted Therapy
- Proto-Oncogene Proteins B-raf
- Stromal Cells